Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience
Lucie Lafay‐Cousin(Women & Children's Hospital of Buffalo), Éric Bouffet(Hospital for Sick Children), Katrin Scheinemann(University of Lucerne), Taryn B. Fay‐McClymont(Alberta Children's Hospital), L. Janzen(Barwon Health), Annie Huang(Hospital for Sick Children), Adam Fleming(Montreal Children's Hospital), Donna L. Johnston(Children's Hospital of Eastern Ontario), Sharon Guger(Hospital for Sick Children), Donald Mabbott(University of Toronto), Juliette Hukin(BC Children's Hospital), Douglas Strother(Women & Children's Hospital of Buffalo), Chris Fryer(BC Children's Hospital)
Cited by 41
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795